Board Meeting30 Jul 2026, 05:00 pm
Torrent Pharma Board Approves Unaudited Financial Results for Q1 FY27
AI Summary
Torrent Pharmaceuticals Ltd. announced that its Board of Directors has approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company will publish an extract of the consolidated financial results as per listing regulations and will make both standalone and consolidated results available on its website. A press release detailing the financial results has also been issued. Additionally, the company noted that Ameera Shah will complete her term as an Independent Director on August 1, 2026. The Board meeting commenced at 2:00 PM and concluded at 4:40 PM.
Key Highlights
- Board approved unaudited standalone and consolidated financial results for Q1 FY27.
- Financial results will be published and available on the company website.
- Ameera Shah completes term as Independent Director on August 1, 2026.
- Limited review report by B S R & Co. LLP is included.
- Results prepared in accordance with Ind AS 34 and Listing Regulations.
Price Impact
More from TORNTPHARM